Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Revenue | 9M | 20M | 62M | 58M |
| Research and development | 44M | 52M | 56M | 52M |
| Selling, general and administrative | 19M | 20M | 18M | 22M |
| Operating income | −54M | −52M | −13M | −57M |
| Pre-tax income | −49M | −49M | −8M | −58M |
| Income tax | 0 | 0 | 0 | 0 |
| Net income | −49M | −49M | −8M | −58M |
| Earnings per share | −0.55 | −0.61 | −0.09 | −0.73 |
| Earnings per share, diluted | −0.55 | −0.61 | −0.09 | −0.73 |
| Metric | 19/08/2026 | 18/08/2026 | 31/12/2025 | 30/04/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | — | 28M | — | 66M | 71M | 84M | 104M |
| Receivables | — |
| Metric | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Operating cash flow | −53M | −7M | −33M | −19M |
| Depreciation and amortisation | 1M | 2M | 5M | 45M |
| Share-based compensation | 3M | 4M | 4M | 4M |
| Capital expenditure |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| — |
| 12M |
| — |
| 5M |
| 56M |
| 38M |
| — |
| Current assets | — | — | 47M | — | 86M | 148M | 140M | — |
| Total assets | — | — | 63M | — | 111M | 175M | 199M | — |
| Current liabilities | — | — | 37M | — | 33M | 40M | 41M | — |
| Equity | — | — | −22M | — | 9M | 52M | 54M | 107M |
| Shares issued | — | — | — | 92M | 84M | 81M | 80M | 80M |
| 140,000 |
| 391,000 |
| 351,000 |
| 535,000 |
| Investing cash flow | 7M | 9M | 21M | 2M |
| Financing cash flow | 6M | −6M | −2M | −2M |